Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002052 · ClinicalTrials.gov registry record · NA
Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
NCT00002052: Completed NA study, sponsored by University of Southern California.
NCT00002052 is a NA study that has completed, run by University of Southern California. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002052, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To compare the effectiveness of standard treatment with parenteral ampicillin and oral amoxicillin compared to initial daily therapy with ceftriaxone followed by 3 times weekly suppressive treatment for salmonella infections in AIDS patients.
Interventions
- DRUG Amoxicillin trihydrate
- DRUG Ceftriaxone sodium
- DRUG Ampicillin sodium
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002052 record still lists
NCT00002052 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 3 interventions - of which Amoxicillin trihydrate is the first listed.
NCT00002052 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002052 about?
NCT00002052 is a clinical study titled "Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients". To compare the effectiveness of standard treatment with parenteral ampicillin and oral amoxicillin compared to initial daily therapy with ceftriaxone followed by 3 times weekly suppressive treatment for salmonella infections in AIDS patients.
What is the current status of trial NCT00002052?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002052?
The interventions under investigation include: Amoxicillin trihydrate (DRUG), Ceftriaxone sodium (DRUG), Ampicillin sodium (DRUG).
Who is sponsoring clinical trial NCT00002052?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.